• Vt. to get $1.1 million drug settlement
    November 17,2012
     

    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.

    MORE IN This Just In
    MORRISVILLE – Overtime magic from Chloe Schiff and Maralina Moore gave the Solons a huge... Full Story
    BARRE TOWN – The Raiders proved that records mean little with Friday’s victory over their... Full Story
    WILLIAMSTOWN — Life just keeps getting better for the undefeated Blue Devils. Full Story
    More Articles
  •  
     
    • MEDIA GALLERY 
    • VIDEOS
    • PHOTOS